| Pregabalin | Duloxetine | ||||
---|---|---|---|---|---|---|
No | DDI | Â | No | DDI | Â | |
DDI present | present | Â | DDI present | present | Â | |
 | n = 433 | n = 13 | Pvalue* | n = 193 | n = 253 | Pvalue* |
All-Cause Inpatient Visits | Â | Â | Â | Â | Â | Â |
Members with Hospitalization | 123 (28.4%) | 1 (7.7%) | ** | 49 (25.4%) | 90 (35.6%) | 0.0214 |
Hospitalizations Per Member, Mean (SD) | 0.9 (2.8) | 0.1 (0.3) | 0.0897 | 0.5 (1.9) | 1.3 (3.9) | 0.0059 |
All-Cause Emergency Room Visits | Â | Â | Â | Â | Â | Â |
Members with Visit | 100 (23.1%) | 3 (23.1%) | ** | 40 (20.7%) | 83 (32.8%) | 0.0047 |
Visits per Member, Mean (SD) | 0.5 (1.2) | 0.6 (1.2) | 0.8068 | 0.4 (1.0) | 0.7 (1.2) | 0.0035 |
All-Cause Outpatient Visits (non-physical therapy) | Â | Â | Â | Â | Â | Â |
Members with Visit | 427 (98.6%) | 13 (100.0%) | ** | 190 (98.4%) | 250 (98.8%) | ** |
Visits per Member, Mean (SD) | 14.6 (12.6) | 12.8 (9.1) | 0.7728 | 15.2 (13.6) | 17.3 (11.1) | 0.0044 |
All-Cause Physical Therapy Visits | Â | Â | Â | Â | Â | Â |
Members with Visit | 57 (13.2%) | 2 (15.4%) | ** | 33 (17.1%) | 32 (12.6%) | 0.1869 |
Visits per Member, Mean (SD) | 0.8 (3.1) | 0.3 (0.9) | 0.8733 | 1.0 (4.1) | 0.9 (3.5) | 0.2342 |